Abstract:The difluoromethylene analogue of aspartyl phosphate 6 has been prepared by the fluoride catalysed coupling of diethyl trimethylsilyldifluoromethyl phosphonate with an appropriate aldehyde followed by Dess-Martin oxidation and deprotection; the deprotected compound inhibited (KI 95 microM) aspartate semi-aldehyde dehydrogenase, a key enzyme involved in bacterial amino acid and peptidoglycan biosynthesis.
“…14 The most potent synthetic inhibitor of ASADH identified to date is the difluorophosphonate analog of aspartyl phosphate with a K i of 95 mM. 15,16 In addition to its role in aspartate metabolism, ASADH from the archaea Sulfolobus solfataricus has been shown recently to exhibit RNase activity. 17 The RNase activity has been localized within the N-terminal 73 amino acid residues, which is part of the nucleotide-binding domain of ASADH.…”
“…14 The most potent synthetic inhibitor of ASADH identified to date is the difluorophosphonate analog of aspartyl phosphate with a K i of 95 mM. 15,16 In addition to its role in aspartate metabolism, ASADH from the archaea Sulfolobus solfataricus has been shown recently to exhibit RNase activity. 17 The RNase activity has been localized within the N-terminal 73 amino acid residues, which is part of the nucleotide-binding domain of ASADH.…”
“…Perturbations to the asd gene have been shown to be lethal to the microorganism, and bacterial strains with this gene deletion are auxotrophic for DAP (4). Because of the importance of this enzyme in amino acid biosynthesis, there is an ongoing interest in the development of effective microbial ASADH inhibitors (5)(6)(7).…”
The structural analysis of an enzymatic reaction intermediate affords a unique opportunity to study a catalytic mechanism in extraordinary detail. Here we present the structure of a tetrahedral intermediate in the catalytic cycle of aspartate--semialdehyde dehydrogenase (ASADH) from Haemophilus influenzae at 2.0-Å resolution. ASADH is not found in humans, yet its catalytic activity is required for the biosynthesis of essential amino acids in plants and microorganisms. Diaminopimelic acid, also formed by this enzymatic pathway, is an integral component of bacterial cell walls, thus making ASADH an attractive target for the development of new antibiotics. This enzyme is able to capture the substrates aspartate--semialdehyde and phosphate as an active complex that does not complete the catalytic cycle in the absence of NADP. A distinctive binding pocket in which the hemithioacetal oxygen of the bound substrate is stabilized by interaction with a backbone amide group dictates the R stereochemistry of the tetrahedral intermediate. This pocket, reminiscent of the oxyanion hole found in serine proteases, is completed through hydrogen bonding to the bound phosphate substrate.
“…ASA (8) itself was synthesised from allylglycine in a simple procedure involving ozonolysis in 1 M aqueous HCl followed by treatment with dimethyl sulfide. [22] The resulting aqueous solution containing ASA (8) and dimethyl sulfoxide (DMSO) was stable when stored at À 20 8C for prolonged periods, showing no diminished activity in ASA-DH assays over time.…”
Section: Enzyme Assaysmentioning
confidence: 99%
“…The enzyme utilises phosphate as an excellent nucleofuge and we reasoned that attenuation of the leaving group ability could provide inhibitory compounds. Thus, difluorophosphonate 12 [8] and phosphonate 13 were considered as potential substrate mimics. In the case of the difluorophosphonate 12 it could reasonably be expected that enhanced electrophilicity of the g-carbonyl group could lead to significant covalent attachment to the active site nucleophile.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.